Abstract
Electrochemical behavior of disopyramide (DPA) on glassy carbon electrode (GCE) was investigated by using cyclic voltammetry, square-wave voltammetry and constant potential bulk electrolysis. Adsorption and diffusion properties of DPA were evaluated. Differential pulse anodic adsorptive stripping voltammetric (DPAAdSV) and squarewave anodic adsorptive stripping voltammetric (SWAAdSV) methods were developed for its direct determination in pharmaceutical preparations and biological samples. Linear working concentration range for both methods was found as 3x10-7 M (0.102 mg/L) - 3x10-6 M (1.0 mg/L). Limit of detection and limit of quantitation for DPAAdSV were found to be 2.9x10-7 M (0.10 mg/L) and 9.5x10-7 M (0.32 mg/L), respectively and they were calculated to be 1.4x10-7 M (0.05 mg/L) and 4.5x10-7 M (0.15 mg/L) for SWAAdSV. Proposed methods were successfully applied to determine the content of DPA in pharmaceutical preparations and biological samples.
Keywords: Disopyramide, Electrochemical behavior, Voltammetric stripping methods, Assay, Glassy carbon electrode, Limit of detection, Limit of quantitation, Pharmaceutical preparations, Biological samples, Validation parameters
Current Pharmaceutical Analysis
Title: Voltammetric Stripping Methods for Direct Determination of Disopyramide
Volume: 8 Issue: 1
Author(s): Muharrem Duran, Zehra Durmus, Ibrahim H. Tasdemir and Esma Kilic
Affiliation:
Keywords: Disopyramide, Electrochemical behavior, Voltammetric stripping methods, Assay, Glassy carbon electrode, Limit of detection, Limit of quantitation, Pharmaceutical preparations, Biological samples, Validation parameters
Abstract: Electrochemical behavior of disopyramide (DPA) on glassy carbon electrode (GCE) was investigated by using cyclic voltammetry, square-wave voltammetry and constant potential bulk electrolysis. Adsorption and diffusion properties of DPA were evaluated. Differential pulse anodic adsorptive stripping voltammetric (DPAAdSV) and squarewave anodic adsorptive stripping voltammetric (SWAAdSV) methods were developed for its direct determination in pharmaceutical preparations and biological samples. Linear working concentration range for both methods was found as 3x10-7 M (0.102 mg/L) - 3x10-6 M (1.0 mg/L). Limit of detection and limit of quantitation for DPAAdSV were found to be 2.9x10-7 M (0.10 mg/L) and 9.5x10-7 M (0.32 mg/L), respectively and they were calculated to be 1.4x10-7 M (0.05 mg/L) and 4.5x10-7 M (0.15 mg/L) for SWAAdSV. Proposed methods were successfully applied to determine the content of DPA in pharmaceutical preparations and biological samples.
Export Options
About this article
Cite this article as:
Duran Muharrem, Durmus Zehra, H. Tasdemir Ibrahim and Kilic Esma, Voltammetric Stripping Methods for Direct Determination of Disopyramide, Current Pharmaceutical Analysis 2012; 8 (1) . https://dx.doi.org/10.2174/157341212798995584
DOI https://dx.doi.org/10.2174/157341212798995584 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oxidative-Nitrosative Stress In Hypertension
Current Vascular Pharmacology Proteome and Metabolome Alterations in Heart and Liver Indicate Compromised Energy Production During Sepsis
Protein & Peptide Letters Microvascular Function/Dysfunction Downstream a Coronary Stenosis
Current Pharmaceutical Design Challenges in Managing Amniotic Fluid Embolism: An Up-to-Date Perspective on Diagnostic Testing with Focus on Novel Biomarkers and Avenues for Future Research
Current Pharmaceutical Biotechnology Potential Adverse Effects Associated with Inhibition of p38α/β MAP Kinases
Current Topics in Medicinal Chemistry Biotechnological Engineering of Heparin/Heparan Sulphate: A Novel Area of Multi-Target Drug Discovery
Current Pharmaceutical Design Mitochondrial Diseases in Childhood
Current Molecular Medicine Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design Metabolomics and the Diagnosis of Human Diseases -A Guide to the Markers and Pathophysiological Pathways Affected
Current Medicinal Chemistry Impacts of Nanoparticles on Cardiovascular Diseases: Modulating Metabolism and Function of Endothelial Cells
Current Drug Metabolism Endothelial Dysfunction: Methods of Assessment and Application to Hypertension
Current Pharmaceutical Design Pharmacogenomic Considerations in the Treatment of the Pediatric Cardiomyopathy Called Barth Syndrome
Recent Patents on Biotechnology COVID-19: The Significance of Platelets, Mitochondria, Vitamin D, Serotonin and the Gut Microbiota
Current Medicinal Chemistry An Insight of Novel Pharmacological Therapies in Hypertrophic Cardiomyopathy
Medicinal Chemistry Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Current Pharmaceutical Design Transthyretin Deposition in Familial Amyloidotic Polyneuropathy
Current Medicinal Chemistry Methods to Evaluate the Inhibition of TTR Fibrillogenesis Induced by Small Ligands
Current Medicinal Chemistry Out-of-Hospital Cardiac Arrest –Optimal Management
Current Cardiology Reviews Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Current Neuropharmacology Umbilical Cord Tissue Mesenchymal Stem Cells: Characterization and Clinical Applications
Current Stem Cell Research & Therapy